THG indictment
This article was originally published in The Tan Sheet
Executive Summary
San Francisco grand jury returns 42-count indictment against four defendants associated with distributing anabolic steroids including tetrahydragestrinone (THG), Justice Department announces Feb. 12. Case was brought by FDA Commissioner Mark McClellan, MD/PhD, Attorney General John Ashcroft, IRS Commissioner Mark Everson and U.S. Attorney Kevin Ryan. Charges include conspiracy to possess with intent to distribute anabolic steroids, violating the FD&C Act by misbranding THG and failing to correctly label the drug being sold. The indictment also alleges six separate occasions in which steroids actually were distributed to athletes. The four defendants are Bay Area Lab Cooperative President Victor Conte and VP James Valente, personal trainer Greg Anderson and track coach Remi Korchemny. THG previously was marketed as a dietary supplement, but was banned by FDA in October (1"The Tan Sheet" Nov. 3, 2003, p. 14)...
You may also be interested in...
THG Controversy Spotlights Growing Sports Supplement Concerns
FDA's ban of tetrahydrogestrinone (THG) represents another black eye for sports supplements, coinciding with the highly publicized debate over the safety of ephedra-containing products
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.